US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Polyrizon Ltd.

7.33

+4.17131.96%

Post-market: 6.66-0.6689-9.13%16:39 EST

Volume:147.97M

Turnover:1.02B

Market Cap:7.64M

PE:- -

High:8.36

Open:6.97

Low:5.85

Close:3.16

52wk High:7,200.00

52wk Low:2.88

Shares:1.04M

Float Shares:996.80K

Volume Ratio:1,941.94

T/O Rate:14844.30%

Dividend:- -

Dividend Rate:- -

ROE:-12.20%

ROA:-22.25%

PB:0.42

PE(LYR):- -

Loading ...

Overview Company News Filings

Top Midday Gainers

MT Newswires Live

Gold Down Over 1%; Signet Shares Fall After Q3 Results

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM

Polyrizon Achieves Key Manufacturing Milestone for Nasal Spray Platform

Polyrizon Ltd trading halted, news pending

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Why Is Polyrizon Stock (PLRZ) Down Today?

Polyrizon: Announces That It Will Effect a Reverse Share Split of Co's Ordinary Shares at the Ratio of 1-for-6 - SEC Filing

THOMSON REUTERS

Polyrizon Announces 1-for-6 Reverse Stock Split

BRIEF-Polyrizon Files For Mixed Shelf Of Upto $50 Million - SEC Filing

Polyrizon files $50M mixed securities shelf

Polyrizon Files for Mixed Shelf of Upto $50 Mln - SEC Filing

THOMSON REUTERS

BRIEF-Polyrizon Announces Positive In-Vitro Results For PL-16 Viral Blocker

Polyrizon Ltd - Announces Positive in-Vitro Results for Pl-16 Viral Blocker

THOMSON REUTERS

Polyrizon Reports Nasal Gel Blocks Broad Range of Respiratory Viruses in Lab Tests

Polyrizon Ltd. Announces Positive Pre-Clinical Results for PL-14 Allergy Blocker, Paving Way for Clinical Trials

Polyrizon Announces Positive Pre-Clinical Results: Pl-14 Demonstrates Encouraging Allergen-Blocking Efficacy

THOMSON REUTERS

Polyrizon Submits Pre-Sub Package to the FDA for Pl-14 Allergy Blocker

THOMSON REUTERS

Polyrizon Ltd. Reports Improved Financial Position as of June 2025

Polyrizon Ltd. Announces Successful Preclinical Results for Intranasal PL-14 Allergy Blocker, Paving Way for Clinical Trials

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLRZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":7.33,"timestamp":1764709200000,"preClose":3.16,"halted":0,"volume":147968030,"hourTrading":{"tag":"盘后","latestPrice":6.6611,"preClose":7.33,"latestTime":"16:39 EST","volume":756065,"amount":5189503.14108,"timestamp":1764711547628},"delay":0,"floatShares":996800,"shares":1041700,"eps":0,"marketStatus":"Post-Mkt","change":4.17,"latestTime":"12-02 16:39:08 EST","open":6.97,"high":8.36,"low":5.8501,"amount":1018045792.8372201,"amplitude":0.794272,"askPrice":6.67,"askSize":51,"bidPrice":6.62,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":3.16,"preHourTrading":{"tag":"盘前","latestPrice":6.9698,"preClose":3.16,"latestTime":"09:29 EST","volume":19298624,"amount":125571655.5781952,"timestamp":1764685799989},"postHourTrading":{"tag":"盘后","latestPrice":6.6611,"preClose":7.33,"latestTime":"16:39 EST","volume":756065,"amount":5189503.14108,"timestamp":1764711547628},"volumeRatio":1941.939603},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","floatShares":996800,"roa":"-22.25%","roe":"-12.20%","lyrEps":0,"volumeRatio":1941.939603,"shares":1041700,"dividePrice":0,"high":8.36,"amplitude":0.794272,"preClose":3.16,"low":5.8501,"week52Low":2.88,"pbRate":"0.42","week52High":7200.0005,"institutionHeld":0,"latestPrice":7.33,"committee":-0.961538,"eps":0,"divideRate":0,"volume":147968030,"delay":0,"ttmEps":0,"open":6.97,"prevYearClose":3255,"prevWeekClose":3.21,"prevMonthClose":3.21,"prevQuarterClose":6.48,"fiveDayClose":4.08,"twentyDayClose":5.9448,"sixtyDayClose":5.9946},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLRZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-28","symbol":"PLRZ","defaultRemindTime":1764340200000,"type":"split","dateTimestamp":1764306000000,"forFactor":6,"toFactor":1,"ratio":6},{"market":"US","date":"2025-05-27","symbol":"PLRZ","defaultRemindTime":1748352600000,"type":"split","dateTimestamp":1748318400000,"forFactor":250,"toFactor":1,"ratio":250}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLRZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLRZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLRZ","date":"2025-12-01","current":-5.587228,"percent":0.391144,"low":-29.515607,"twenty":-8.098364,"median":-4.512078,"eighty":-1.509837,"high":-0.011381,"avg":-5.114954,"sd":3.90145,"marketCap":6335917},"quantilePoints":[{"date":"2024-10-31","current":-13.097935,"twenty":-22.948538,"median":-13.097935,"eighty":-12.489816,"marketCap":7858761},{"date":"2024-11-08","current":-3.903419,"twenty":-12.692522,"median":-4.690878,"eighty":-4.316449,"marketCap":3891709},{"date":"2024-11-15","current":-2.661127,"twenty":-9.219549,"median":-4.249136,"eighty":-3.530862,"marketCap":2653144},{"date":"2024-11-22","current":-2.985655,"twenty":-4.737156,"median":-3.736612,"eighty":-3.09924,"marketCap":2976698},{"date":"2024-11-29","current":-3.042447,"twenty":-4.451075,"median":-3.375089,"eighty":-3.037515,"marketCap":3033320},{"date":"2024-12-06","current":-3.212824,"twenty":-4.383762,"median":-3.342636,"eighty":-3.042447,"marketCap":3203186},{"date":"2024-12-13","current":-3.375088,"twenty":-4.191157,"median":-3.358862,"eighty":-3.047315,"marketCap":3364963},{"date":"2024-12-20","current":-7.561496,"twenty":-4.383762,"median":-3.375088,"eighty":-3.07146,"marketCap":7538812},{"date":"2024-12-27","current":-5.744141,"twenty":-5.095085,"median":-3.407542,"eighty":-3.090153,"marketCap":5726909},{"date":"2025-01-03","current":-5.938858,"twenty":-6.101122,"median":-3.569805,"eighty":-3.132991,"marketCap":5921041},{"date":"2025-01-10","current":-4.997727,"twenty":-6.159537,"median":-3.796975,"eighty":-3.146231,"marketCap":4982734},{"date":"2025-01-17","current":-6.142316,"twenty":-6.098128,"median":-3.933764,"eighty":-3.167391,"marketCap":6123889},{"date":"2025-01-24","current":-5.889893,"twenty":-6.192801,"median":-4.333277,"eighty":-3.193353,"marketCap":5872223},{"date":"2025-01-31","current":-5.553327,"twenty":-6.125488,"median":-4.527162,"eighty":-3.214122,"marketCap":5536667},{"date":"2025-02-07","current":-4.552045,"twenty":-6.087615,"median":-4.738105,"eighty":-3.227753,"marketCap":4538389},{"date":"2025-02-14","current":-4.711914,"twenty":-6.064471,"median":-4.705652,"eighty":-3.245278,"marketCap":4697778},{"date":"2025-02-21","current":-4.522596,"twenty":-6.049761,"median":-4.627772,"eighty":-3.258259,"marketCap":4509028},{"date":"2025-02-28","current":-3.707687,"twenty":-6.000655,"median":-4.535397,"eighty":-3.316674,"marketCap":3696564},{"date":"2025-03-07","current":-3.460732,"twenty":-5.929065,"median":-4.501561,"eighty":-3.241954,"marketCap":3450350},{"date":"2025-03-14","current":-1.846098,"twenty":-5.873065,"median":-4.396383,"eighty":-3.213473,"marketCap":2852222},{"date":"2025-03-21","current":-1.508371,"twenty":-5.793429,"median":-4.291207,"eighty":-3.160314,"marketCap":2330433},{"date":"2025-03-28","current":-1.353625,"twenty":-5.705978,"median":-3.977976,"eighty":-3.07146,"marketCap":2091350},{"date":"2025-04-04","current":-0.974631,"twenty":-5.536499,"median":-3.903419,"eighty":-3.030526,"marketCap":1505805},{"date":"2025-04-11","current":-0.980061,"twenty":-5.4398,"median":-3.702849,"eighty":-2.640357,"marketCap":1514194},{"date":"2025-04-17","current":-0.985491,"twenty":-5.322255,"median":-3.619184,"eighty":-1.846098,"marketCap":1522583},{"date":"2025-04-25","current":-0.947483,"twenty":-5.174691,"median":-3.5049,"eighty":-1.520317,"marketCap":1463861},{"date":"2025-05-02","current":-0.687943,"twenty":-5.159991,"median":-3.434137,"eighty":-1.353625,"marketCap":1062872},{"date":"2025-05-09","current":-2.602277,"twenty":-5.095085,"median":-3.375088,"eighty":-1.466019,"marketCap":4020518},{"date":"2025-05-16","current":-0.039201,"twenty":-5.02132,"median":-3.354145,"eighty":-1.299871,"marketCap":60566},{"date":"2025-05-23","current":-0.018499,"twenty":-5.006408,"median":-3.310183,"eighty":-1.057434,"marketCap":28581},{"date":"2025-05-30","current":-0.022023,"twenty":-4.999463,"median":-3.245278,"eighty":-1.021327,"marketCap":34025},{"date":"2025-06-06","current":-0.014912,"twenty":-4.937359,"median":-3.214447,"eighty":-0.978975,"marketCap":23039},{"date":"2025-06-13","current":-0.018851,"twenty":-4.922267,"median":-3.183486,"eighty":-0.945854,"marketCap":29125},{"date":"2025-06-20","current":-0.013358,"twenty":-4.871782,"median":-3.155299,"eighty":-0.895899,"marketCap":20638},{"date":"2025-06-27","current":-2.431375,"twenty":-4.817057,"median":-3.116926,"eighty":-0.895899,"marketCap":3756474},{"date":"2025-07-03","current":-2.428961,"twenty":-4.79003,"median":-3.054617,"eighty":-0.90676,"marketCap":3752744},{"date":"2025-07-11","current":-2.469311,"twenty":-4.75787,"median":-3.036282,"eighty":-0.929565,"marketCap":3815085},{"date":"2025-07-18","current":-3.343916,"twenty":-4.728069,"median":-3.039365,"eighty":-0.942596,"marketCap":5166350},{"date":"2025-07-25","current":-4.793774,"twenty":-4.784488,"median":-3.066787,"eighty":-0.954976,"marketCap":7406381},{"date":"2025-08-01","current":-9.134632,"twenty":-4.922267,"median":-3.137242,"eighty":-0.969039,"marketCap":14113006},{"date":"2025-08-08","current":-8.476938,"twenty":-5.004125,"median":-3.155299,"eighty":-0.973817,"marketCap":13096869},{"date":"2025-08-15","current":-8.18463,"twenty":-5.134029,"median":-3.19779,"eighty":-0.976803,"marketCap":12645253},{"date":"2025-08-22","current":-7.746168,"twenty":-5.410414,"median":-3.21607,"eighty":-0.982233,"marketCap":11967829},{"date":"2025-08-29","current":-7.600014,"twenty":-5.856236,"median":-3.245278,"eighty":-0.987228,"marketCap":11742021},{"date":"2025-09-05","current":-7.819245,"twenty":-6.049761,"median":-3.325781,"eighty":-0.992223,"marketCap":12080733},{"date":"2025-09-12","current":-7.143282,"twenty":-6.209629,"median":-3.343916,"eighty":-1.006667,"marketCap":11036370},{"date":"2025-09-19","current":-10.354516,"twenty":-6.696876,"median":-3.375088,"eighty":-1.026648,"marketCap":11742021},{"date":"2025-09-26","current":-11.070023,"twenty":-7.035762,"median":-3.443585,"eighty":-1.030557,"marketCap":12553406},{"date":"2025-10-03","current":-11.383325,"twenty":-7.364852,"median":-3.487865,"eighty":-1.042883,"marketCap":12908691},{"date":"2025-10-10","current":-13.054272,"twenty":-7.512322,"median":-3.569805,"eighty":-1.058791,"marketCap":14803545},{"date":"2025-10-17","current":-11.174457,"twenty":-7.59231,"median":-3.644879,"eighty":-1.068565,"marketCap":12671834},{"date":"2025-10-24","current":-11.278891,"twenty":-7.731553,"median":-3.707687,"eighty":-1.123948,"marketCap":12790262},{"date":"2025-10-31","current":-10.75672,"twenty":-7.950784,"median":-3.905854,"eighty":-1.280758,"marketCap":12198121},{"date":"2025-11-07","current":-9.567215,"twenty":-8.038476,"median":-3.996712,"eighty":-1.310622,"marketCap":10849222},{"date":"2025-11-14","current":-8.045608,"twenty":-8.360015,"median":-4.312242,"eighty":-1.376104,"marketCap":9123720},{"date":"2025-11-21","current":-6.109399,"twenty":-8.170015,"median":-4.417419,"eighty":-1.474489,"marketCap":6928059},{"date":"2025-11-28","current":-5.587228,"twenty":-8.111553,"median":-4.501561,"eighty":-1.508371,"marketCap":6335917},{"date":"2025-12-01","current":-5.587228,"twenty":-8.098364,"median":-4.512078,"eighty":-1.509837,"marketCap":6335917}],"updateTime":1764709741956},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLRZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588063629","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2588063629","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588063629?lang=en_us&edition=fundamental","pubTime":"2025-12-03 03:15","pubTimestamp":1764702931,"startTime":"0","endTime":"0","summary":"Polyrizon , a biotechnology company developing intranasal products, reported Tuesday the \"successful\" completion of a major manufacturing upscaling milestone for its nasal-spray product platform.Shares surged 140% as intraday trading volume catapulted to over 124.9 million from a daily average of about 181,000.Eventbrite  said it has agreed to be acquired by Bending Spoons in an all-cash transaction valued at about $500 million.Shares soared 78% as intraday trading volume surged to over 25.9 million from a daily average of roughly 557,000.Credo Technology  shares jumped 13% amid heavy trading after the firm reported overnight higher fiscal Q2 adjusted earnings and revenue.Trading volume climbed to more than 13.2 million from a daily average of about 6.29 million.Price: 7.38, Change: +4.22, Percent Change: +133.54","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009354923.USD","LU0082616367.USD","PLRZ","LU1861215975.USD","BK4077","LU2360107168.USD","BK4585","LU0053671581.USD","LU1861220033.SGD","BK4108","BK4588","EB","LU0719512351.SGD","BK4141","LU2290526834.HKD"],"gpt_icon":1},{"id":"2588050489","title":"Gold Down Over 1%; Signet Shares Fall After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050489","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588050489?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:29","pubTimestamp":1764696559,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49166700/gold-down-over-1-signet-shares-fall-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4200","BK4539","LU1548497426.USD","LU1861220033.SGD","LU2272731782.SGD","LU1861215975.USD","LU0154245756.USD","LU0719512351.SGD","LU1992135472.HKD","BK4077","BK4137","LU1720051017.SGD","LU1923623000.USD","EB","ABTC","LU1951200564.SGD","BK4139","VSTS","BK4608","LU2272731600.USD","BK4023","BK4585","BK4607","SIG","LU2087625088.SGD",".IXIC","BK4588","LU2357305700.SGD","LU2286300806.USD","LU0823434740.USD","LU1992135399.USD","LU0390134368.USD","PLRZ","LU0154245673.USD","BK4116","LU1720051108.HKD","LU0082616367.USD","BK4108","LU0353189680.USD","JANX","BK4613","LU1951198990.SGD","LU0353189763.USD","LU0823434583.USD"],"gpt_icon":1},{"id":"2588051902","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:43 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2588051902","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588051902?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:43","pubTimestamp":1764686583,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:43 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nAQN2LBQ6N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2588053510","title":"Polyrizon Achieves Key Manufacturing Milestone for Nasal Spray Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053510","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588053510?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:55","pubTimestamp":1764680110,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced the successful completion of a major manufacturing upscaling milestone for its proprietary nasal-spray product platform, based on its Capture & Contain (C&C) technology. The company, in collaboration with its CDMO partner, successfully transitioned from small-batch laboratory production to a larger-scale manufacturing run, validating the ability to produce its PL-14 intranasal protective spray at higher volumes while maintaining quality standards. PL-14 is designed to create a fast-acting, moisturizing barrier in the nasal cavity to trap and neutralize airborne allergens. The upscaled manufacturing process will support the production of clinical trial material, with clinical trials expected to begin in 2026. The results of this milestone were announced and have not yet been presented in a scientific forum.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL67m5mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4585","LU2210150020.SGD","PLRZ","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK4112","IE00B3QW5Z07.USD","NDAQ","BK4588"],"gpt_icon":0},{"id":"2586945752","title":"Polyrizon Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2586945752","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586945752?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:50","pubTimestamp":1764204627,"startTime":"0","endTime":"0","summary":"19:50 EST Polyrizon (PLRZ) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2586291092","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2586291092","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586291092?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:50","pubTimestamp":1764204600,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nAQN2LB6DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2586471633","title":"Why Is Polyrizon Stock (PLRZ) Down Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586471633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586471633?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:34","pubTimestamp":1764081284,"startTime":"0","endTime":"0","summary":"Polyrizon stock fell hard after the company announced a reverse stock split for later this week.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-polyrizon-stock-plrz-down-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-polyrizon-stock-plrz-down-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2586047347","title":"Polyrizon: Announces That It Will Effect a Reverse Share Split of Co's Ordinary Shares at the Ratio of 1-for-6 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586047347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586047347?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:03","pubTimestamp":1764075810,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2586473444","title":"Polyrizon Announces 1-for-6 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473444","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586473444?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:01","pubTimestamp":1764075673,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced a reverse share split of its ordinary shares at a ratio of 1-for-6, consolidating every six shares into one. The company's ordinary shares will begin trading on the Nasdaq Capital Market on a post-split basis starting November 28, 2025. The number of issued and outstanding shares will be adjusted accordingly, and fractional shares will be rounded as specified. The company's authorized share capital will remain unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL7RBkMm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2581572832","title":"BRIEF-Polyrizon Files For Mixed Shelf Of Upto $50 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581572832","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581572832?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:20","pubTimestamp":1762554002,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Files For Mixed Shelf Of Upto $50 Million - SEC FilingPolyrizon Ltd PLRZ.O:POLYRIZON FILES FOR MIXED SHELF OF UPTO $50 MILLION - SEC FILINGSource text: [ID:n0001213900-25-107627]Further company coverage: PLRZ.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2581834835","title":"Polyrizon files $50M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581834835?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:20","pubTimestamp":1762550425,"startTime":"0","endTime":"0","summary":"16:17 EST Polyrizon (PLRZ) files $50M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-files-50m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-files-50m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2581831575","title":"Polyrizon Files for Mixed Shelf of Upto $50 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581831575?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:17","pubTimestamp":1762550251,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2581099363","title":"BRIEF-Polyrizon Announces Positive In-Vitro Results For PL-16 Viral Blocker","url":"https://stock-news.laohu8.com/highlight/detail?id=2581099363","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581099363?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:56","pubTimestamp":1762437418,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Announces Positive In-Vitro Results For PL-16 Viral BlockerNov 6 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON LTD - ANNOUNCES POSITIVE IN-VITRO RESULTS FOR PL-16 VIRAL BLOCKERSource text: ID:nGNXgfZbxFurther company coverage: PLRZ.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI29C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2581209933","title":"Polyrizon Ltd - Announces Positive in-Vitro Results for Pl-16 Viral Blocker","url":"https://stock-news.laohu8.com/highlight/detail?id=2581209933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581209933?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:56","pubTimestamp":1762437372,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI29C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2581409980","title":"Polyrizon Reports Nasal Gel Blocks Broad Range of Respiratory Viruses in Lab Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2581409980","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581409980?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:55","pubTimestamp":1762437312,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced positive in-vitro results for its PL-16 Viral Blocker, a proprietary intranasal gel designed to protect against respiratory viruses. The research demonstrated that the formulation provides broad-spectrum viral blocking, including strong protection against the H1N1 influenza virus, by creating a reversible physical barrier on the nasal mucosa. This non-pharmacological mechanism traps and neutralizes viruses mechanically without cytotoxic effects, supporting the product's safety and efficacy. The company indicated that future development will include clinical studies, pending regulatory approvals, but has not stated whether these research results have been or will be presented at a scientific conference or publication.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL1Pd0gw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","NDAQ","BK4585","LU2095319765.USD","BK4588","LU0314104364.USD","LU2210149790.SGD","BK4112","LU2210150020.SGD"],"gpt_icon":0},{"id":"2573726586","title":"Polyrizon Ltd. Announces Positive Pre-Clinical Results for PL-14 Allergy Blocker, Paving Way for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2573726586","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573726586?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:21","pubTimestamp":1759753276,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced positive results from a recent pre-clinical study evaluating its PL-14 Allergy Blocker, developed using the company's proprietary Capture & Contain (C&C) platform. The study assessed the formulation's ability to create a hydrogel barrier that limits the penetration of Der p 1, a major house dust mite allergen. Results showed that PL-14 significantly restricted allergen diffusion, with only 1.07% passing through after one hour, 1.14% after two hours, and 13.6% after four hours. The allergen concentrations used in the study were substantially higher than typical real-world exposures. The company plans to initiate clinical studies to further support regulatory and clinical development of PL-14 and other candidates within the C&C platform. The pre-clinical results have already been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, thi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL2zZMrx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","BK4112","IE00BKPKM429.USD","NDAQ","PLRZ","IE00BGHQF748.EUR","BK4588","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2573672631","title":"Polyrizon Announces Positive Pre-Clinical Results: Pl-14 Demonstrates Encouraging Allergen-Blocking Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2573672631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573672631?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:21","pubTimestamp":1759753260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA9ZRCLS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2568268903","title":"Polyrizon Submits Pre-Sub Package to the FDA for Pl-14 Allergy Blocker","url":"https://stock-news.laohu8.com/highlight/detail?id=2568268903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568268903?lang=en_us&edition=fundamental","pubTime":"2025-09-19 20:15","pubTimestamp":1758284100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nTUA7RYJWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2568127644","title":"Polyrizon Ltd. Reports Improved Financial Position as of June 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2568127644","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568127644?lang=en_us&edition=fundamental","pubTime":"2025-09-18 04:53","pubTimestamp":1758142431,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. ( ($PLRZ) ) has issued an announcement. Polyrizon Ltd. released its interim condensed financial statements for the period ending Jun...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-reports-improved-financial-position-as-of-june-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-reports-improved-financial-position-as-of-june-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2566497500","title":"Polyrizon Ltd. Announces Successful Preclinical Results for Intranasal PL-14 Allergy Blocker, Paving Way for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2566497500","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566497500?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:26","pubTimestamp":1757676376,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd.  has announced promising preclinical results for its PL-14 Allergy Blocker, as part of its Capture & Contain (C&C) platform. Conducted in collaboration with the University of Parma, the study demonstrated targeted deposition in the nasal vestibule, a critical site for early allergen contact. The PL-14 formulation exhibited over 60% deposition in this region, supporting its potential as a preventive treatment for allergic rhinitis. The study, led by Professor Fabio Sonvico, utilized a validated silicone-based human nasal cast to assess the spray deposition profile. Polyrizon plans to continue preclinical efforts and move towards clinical trials. The global allergen blocker market is projected to grow, with an expected value increase from USD 0.14 billion in 2024 to USD 0.21 billion by 2033.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL5vqlpq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4112","PLRZ","LU0314104364.USD","BK4588","IE00BGHQF748.EUR","LU2210150020.SGD","LU2210149790.SGD","BK4585","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2095319765.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}